Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Idorsia Pharmaceuticals Nordics AB
AB
Active
Org 5594104522
Gustav Iii:S Boulevard 46, 169 73
Solna
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2022
5 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Idorsia Pharmaceuticals Nordics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
9M
18M
28M
37M
8M
2023
22M
2024
32M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
7 512
22 298
31 847
Staff expenses
−4 262
−11 491
−12 445
EBITDA
792
754
140
Depreciation & amort.
—
—
—
EBIT
792
754
140
Net financials
85
71
39
Profit before tax
877
825
179
Tax
−181
−174
−49
Net profit
696
651
130
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
7 625
13 632
15 000
Equity
6 321
6 972
7 101
Long-term debt
—
—
—
Short-term debt
1 304
6 660
7 899
Total debt
1 304
6 660
7 899
Financial ratios
5-year trend
EBITDA margin
0.4%
This company
15.8%
Market median
-97% vs market
2023
2025
Equity ratio
47.3%
This company
38.2%
Market median
+24% vs market
2023
2025
Return on equity
1.8%
This company
18.4%
Market median
-90% vs market
2023
2025
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
2023
2025
Asset turnover
2.12×
This company
1.12×
Market median
+89% vs market
2023
2025
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-12-07 – 2023-12-31
View
PDF
More on Idorsia Pharmaceuticals Nordics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
